SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-236993
Filing Date
2021-08-05
Accepted
2021-08-05 07:35:35
Documents
15
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d215189d8k.htm   iXBRL 8-K 30211
2 EX-99.1 d215189dex991.htm EX-99.1 83917
7 GRAPHIC g215189g0804155912519.jpg GRAPHIC 4784
  Complete submission text file 0001193125-21-236993.txt   298249

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210805.xsd EX-101.SCH 3963
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210805_def.xml EX-101.DEF 14267
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210805_lab.xml EX-101.LAB 23647
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210805_pre.xml EX-101.PRE 15300
8 EXTRACTED XBRL INSTANCE DOCUMENT d215189d8k_htm.xml XML 6809
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 211146347
SIC: 2834 Pharmaceutical Preparations